Acquisition of Stickland-metabolizing bacteria during infancy prevents Clostridium botulinum infection

Authors:

Abstract
The mechanisms by which maturation of the infant gut microbiota promotes resistance to pathogen colonization remain poorly understood. Infant botulism, a potentially fatal disease caused by intestinal colonization by Clostridium botulinum, provides a striking example of age-dependent susceptibility to infection. Although the gut microbiota has long been implicated in protection against C. botulinum, the responsible bacterial species and underlying mechanisms have yet to be elucidated. Here, we show that acquisition of Stickland-metabolizing Clostridia during infant gut microbiota maturation confers resistance to C. botulinum colonization through competition for shared amino-acid-dependent nutritional niches. In human fecal microbiota-transplanted mice, longitudinally collected infant microbiotas exhibited a clear transition from susceptibility to resistance. Intestinal metabolomic analysis identified 5-aminovalerate as a hallmark metabolite of the resistant microbiota, implicating Stickland metabolism, an amino acid metabolic pathway also utilized by C. botulinum. Guided by this finding, metagenomic analysis revealed enrichment of Stickland-metabolizing Clostridia in resistant microbiotas, including Clostridioides difficile, a bacterium frequently carried by healthy infants. Intestinal metabolic signatures of C. botulinum and infant-derived Stickland-metabolizing Clostridia suggested competition for shared amino-acid-dependent nutritional niches. Consistent with this model, C. difficile suppressed C. botulinum expansion through nutrient competition. Together, these findings identify nutritional niche competition as a mechanism by which microbiota maturation promotes resistance to C. botulinum colonization. This work demonstrates how acquisition of specific microbial metabolic functions during early life can shift the gut microbiota from a susceptible to a resistant state.
Funding Information
  • Japan Agency for Medical Research and Development (JP23fk0108688h0001)
  • Japan Agency for Medical Research and Development (JP25wm0325067h0003)
  • Japan Agency for Medical Research and Development (JP21zf0127001)
  • Japan Agency for Medical Research and Development (JP19fm0208010h0003)
  • Japan Society for the Promotion of Science (JSPS) Kakenhi
  • Kanazawa University “JIKO-CHOKOKU” Project
  • Yakult Bio-Science Foundation
  • Hokuriku Bank Research Grant for Young Scientists
  • The Chemo-Sero-Therapeutic Research Institute